Physician profile
Danny J Soares
NPI 1952568370
$16,981.32
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $219 · 2021: $39.27 · 2022: $119 · 2023: $1,488 · 2024: $2,571 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,600 · Travel and Lodging: $3,422 · Food and Beverage: $2,363 · Education: $53.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,600.00 |
| Travel and Lodging | $3,421.58 |
| Food and Beverage | $2,363.33 |
| Education | $53.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $11,618.33 | 2024-2025 | Daxxify |
| Merz North America, INC. | $4,801.98 | 2019-2024 | Xeomin |
| Galderma Laboratories, L.P. | $266.84 | 2024-2025 | Dysport |
| Apyx Medical Corporation | $135.60 | 2020 | |
| Sientra, INC. | $59.34 | 2022 | |
| Allergan, INC. | $45.15 | 2019-2022 | |
| Innovation Technologies INC | $34.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Soares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.